Minerva Neurosciences, Inc share price logo

Minerva Neurosciences, Inc

NASDAQ: NERV

$4.92

-0.18

(-3.63%)

as on

Minerva Neurosciences, Inc Stock Performance

as on July 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.72
    $5.10
    downward going graph

    4.07%

    Downside

    3.66%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.59
    $12.46
    downward going graph

    67.68%

    Downside

    153.25%

    Upside

    downward going graph

Minerva Neurosciences, Inc share price movements today

Previous Close
$5.10
Open
$5.10
Volume
361.5K
Day's Low - High
$4.72 - $5.10
52 Week Low - High
$1.59 - $12.46

Minerva Neurosciences, Inc Historical Returns

1 Month Return
+ 2.82 %
3 Month Return
-2.49 %
1 Year Return
+ 209.09 %
3 Year Return
-50.2 %
5 Year Return
-72.52 %

Minerva Neurosciences, Inc Stock Fundamentals & Key Indicators

Check Minerva Neurosciences, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$237.6M

EPS (TTM)

-0.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-27.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-675.09%

Minerva Neurosciences, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Minerva Neurosciences, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$237.6M-72.52%NA0.00%NA
BUY$40.2B501.91%NA0.00%NA
BUY$41.8B79.37%78.7912.55%NA
BUY$134.0B163.95%31.3635.51%NA
BUY$68.6B12.37%15.9729.65%0.5700000000000001%

Stock Returns calculator for Minerva Neurosciences, Inc Stock including INR - Dollar returns

The Minerva Neurosciences, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Minerva Neurosciences, Inc investment value today

Current value as on today

₹3,31,682

Returns

₹2,31,682

(+231.68%)

Returns from Minerva Neurosciences, Inc Stock

₹1,98,182 (+198.18%)

Dollar Impact

₹33,500 (+33.5%)

Analyst Recommendation on Minerva Neurosciences, Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Minerva Neurosciences, Inc. Average target price of $9.5

Minerva Neurosciences, Inc Share Price Target

Get share price movements and forecasts by analysts on Minerva Neurosciences, Inc.

What analysts predicted

48.21%UPSIDE

Target Price

$9.5

Current Price

$4.92

Analyzed by

6 Analysts

Target

$9.50

Minerva Neurosciences, Inc target price $9.5, a slight upside of 48.21% compared to current price of $4.92. According to 6 analysts rating.

Indian Investors' Interest in Minerva Neurosciences, Inc Stock

Search interest for Minerva Neurosciences, Inc Stock has increased by 60% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:60% versus previous 30 day period

Minerva Neurosciences, Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
0
0
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-7
-6
-6
-4
-4
-3
-3
-2
-4
-16
EBITDA
-6
-6
-5
22
-4
-4
-3
-2
-283
-125
Interest Expense
2
2
2
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-9
-8
-8
22
-4
-3
-3
-2
-283
-125
Income Tax Expense
-5
0
0
0
-
-
-
-
-
-
Net Income
-9
-8
-8
22
-4
-3
-3
-2
-283
-125
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-10119.02%
-8889.51%
0.00%
0.00%
0.00%
0.00%

Minerva Neurosciences, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
41
41
-
-
-
-
-
Gross Profit
0
0
0
0
41
0
0
0
0
0
Operating Income
-30
-41
-51
-75
1
-45
-25
-23
-21
-15
EBITDA
-29
-40
-50
-74
2
-45
-24
-21
6
-293
Interest Expense
1
0
0
1
-
6
7
8
4
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-31
-40
-50
-74
1
-51
-32
-30
1
-293
Income Tax Expense
1
-9
1
-2
0
-1
6
0
-
-
Net Income
-31
-31
-50
-72
1
-49
-32
-30
1
-293
Net Profit Margin
0.00%
0.00%
0.00%
-175.31%
4.71%
0.00%
0.00%
0.00%
0.00%
0.00%

Minerva Neurosciences, Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-8
-8
22
-4
-4
-3
-2
-283
-125,404
Operating Cash Flow
-6
-3
-4
-5
-5
-2
-2
-4
-5,427
Investing Cash Flow
-
-
-
-
-
-
-
-
-45,294
Financing Cash Flow
-
-
-
-
-
-
0
74
1,079
Change in Cash
-6
-3
-4
-5
-5
-2
-2
70
-49,642

Minerva Neurosciences, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-50
-72
1
-49
-32
-30
1
-293
Operating Cash Flow
3
-41
-43
-33
-24
-24
-14
-19
-13,510
Investing Cash Flow
-107
69
14
24
0
0
-
-
-
Financing Cash Flow
47
-3
0
13
60
0
19
-
74,450
Change in Cash
-56
24
-28
3
35
-24
4
-19
60,939

Global Institutional Holdings in Minerva Neurosciences, Inc

Funds
Holdings
Geode Capital Management, LLC
0.73%
JONES FINANCIAL COMPANIES LLLP
0%
Vanguard Fiduciary Trust Co
0.57%
Deutsche Bank AG
0%
Morgan Stanley - Brokerage Accounts
0.03%

Minerva Neurosciences, Inc News & Key Events

  • img

    Today's Timeline - 21 October

    Tue, 06:40 PM

    -

    Minerva Neurosciences announces $200 million funding for roluperidone development, including $80 million upfront for Phase 3 trial.

Insights on Minerva Neurosciences, Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 617.1% return, outperforming this stock by 669.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 416.1% return, outperforming this stock by 205.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NERV stock has moved down by -8.1%

About Minerva Neurosciences, Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
OrganisationMinerva Neurosciences, Inc
Headquarters1500 District Avenue, Burlington, MA, United States, 01803
IndustryBiotechnology
CEODr. Remy Luthringer Ph.D.
E-voting on sharesClick here to vote

Key Management of Minerva Neurosciences, Inc

Name

Title

Dr. Remy Luthringer Ph.D.

Executive Chairman, CEO & Member of Scientific Advisory Board

Mr. Frederick W. Ahlholm CPA

Senior VP, CFO & Secretary

Mr. Joseph Reilly

Senior VP & COO

Mr. William B. Boni

Vice President of Investor Relations & Corporate Communications

Mr. James O'Connor

Chief Business Officer & General Counsel

Prof. Michael Davidson M.D.

Member of Scientific Advisory Board & Chief Medical Officer

FAQs

What is Minerva Neurosciences, Inc share price today?

Minerva Neurosciences, Inc share price today is $4.92 as on at the close of the market. Minerva Neurosciences, Inc share today touched a day high of $5.10 and a low of $4.72.

What is the 52 week high and 52 week low for Minerva Neurosciences, Inc share?

Minerva Neurosciences, Inc share touched a 52 week high of $12.46 on and a 52 week low of $1.59 on . Minerva Neurosciences, Inc stock price today i.e. is closed at $4.92,which is 60.51% down from its 52 week high and 209.43% up from its 52 week low.

What is Minerva Neurosciences, Inc's market capitalisation today?

Minerva Neurosciences, Inc market capitalisation is $0.00T as on .

How to invest in Minerva Neurosciences, Inc Stock (NERV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Minerva Neurosciences, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Minerva Neurosciences, Inc Shares that will get you 0.3049 shares as per Minerva Neurosciences, Inc share price of $4.92 per share as on July 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Minerva Neurosciences, Inc Stock (NERV) from India?

Indian investors can start investing in Minerva Neurosciences, Inc (NERV) shares with as little as ₹95.395 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.95 in Minerva Neurosciences, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Minerva Neurosciences, Inc share’s latest price of $4.92 as on July 7, 2026 at 1:29 am IST, you will get 2.0325 shares of Minerva Neurosciences, Inc. Learn more about fractional shares .

What are the returns that Minerva Neurosciences, Inc has given to Indian investors in the last 5 years?

Minerva Neurosciences, Inc stock has given -72.52% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?